Epimedin B

CAS No. 110623-73-9

Epimedin B ( —— )

Catalog No. M17818 CAS No. 110623-73-9

Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 142 In Stock
10MG 216 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epimedin B
  • Note
    Research use only, not for human use.
  • Brief Description
    Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.
  • Description
    Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    110623-73-9
  • Formula Weight
    808.78
  • Molecular Formula
    C38H48O19
  • Purity
    98%
  • Solubility
    DMSO : 33.33 mg/mL. 41.21 mM;
  • SMILES
    CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)OC6C(C(C(CO6)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Olmutinib

    Olmutinib (HM61713, BI-1482694) is a pontent and T790M-specific third-generation EGFR inhibitor for treatment of NSCLC.

  • Tarloxotinib bromide

    Tarloxotinib bromide is an irreversible inhibitor of EGFR/HER2.

  • Befotertinib

    Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.